Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues

Saved in:
Bibliographic Details
Published in:Controlled clinical trials 2001, Vol.22 (1), p.29-41
Main Authors: PRESSEL, Sara L, DAVIS, Barry R, PARKS, Heather, SIMPSON, Lara M, NWACHUKU, Chuke, FURBERG, Curt D, WRIGHT, Jackson T, GERACI, Therese S, KINGRY, Connie, FORD, Charles E, PILLER, Linda B, BETTENCOURT, Judy, KIMMEL, Barbara, LUSK, Christine
Format: Article
Language:English
Subjects:
Biological and medical sciences
Clinical trial. Drug monitoring
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 41
container_issue 1
container_start_page 29
container_title Controlled clinical trials
container_volume 22
creator PRESSEL, Sara L
DAVIS, Barry R
PARKS, Heather
SIMPSON, Lara M
NWACHUKU, Chuke
FURBERG, Curt D
WRIGHT, Jackson T
GERACI, Therese S
KINGRY, Connie
FORD, Charles E
PILLER, Linda B
BETTENCOURT, Judy
KIMMEL, Barbara
LUSK, Christine
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_870122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>870122</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_8701223</originalsourceid><addsrcrecordid>eNqNjU1Ow0AMhUcIJMLPHSyxgUWkSWiall1UgbqIBIss2FVW6lBDMhON3UI5DidlinoANvbTe5-fT0ySzcp5agv7emoSm83LNJ8U03NzIfJurS2y6SQxP88jBVT2DntAGalVAd-BUhjYxcC9gW4I1v4Lv72wAwzDHxDNyilv9rFAyQnvCNCtoeaR4_SfFA7HTSDUgZyCengJtDvIJWFQqFSx_YgEx9-3VV0vq-YOHmDReyG_VWCRLcmVOeuwF7o-7ktz8_TYLJbpiNJi3wV0LctqDDxg2K9mpc3y_P5_1C9Rg187</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues</title><source>ScienceDirect Freedom Collection</source><creator>PRESSEL, Sara L ; DAVIS, Barry R ; PARKS, Heather ; SIMPSON, Lara M ; NWACHUKU, Chuke ; FURBERG, Curt D ; WRIGHT, Jackson T ; GERACI, Therese S ; KINGRY, Connie ; FORD, Charles E ; PILLER, Linda B ; BETTENCOURT, Judy ; KIMMEL, Barbara ; LUSK, Christine</creator><creatorcontrib>PRESSEL, Sara L ; DAVIS, Barry R ; PARKS, Heather ; SIMPSON, Lara M ; NWACHUKU, Chuke ; FURBERG, Curt D ; WRIGHT, Jackson T ; GERACI, Therese S ; KINGRY, Connie ; FORD, Charles E ; PILLER, Linda B ; BETTENCOURT, Judy ; KIMMEL, Barbara ; LUSK, Christine</creatorcontrib><identifier>ISSN: 0197-2456</identifier><identifier>EISSN: 1879-050X</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Biological and medical sciences ; Clinical trial. Drug monitoring ; General pharmacology ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Controlled clinical trials, 2001, Vol.22 (1), p.29-41</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=870122$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>PRESSEL, Sara L</creatorcontrib><creatorcontrib>DAVIS, Barry R</creatorcontrib><creatorcontrib>PARKS, Heather</creatorcontrib><creatorcontrib>SIMPSON, Lara M</creatorcontrib><creatorcontrib>NWACHUKU, Chuke</creatorcontrib><creatorcontrib>FURBERG, Curt D</creatorcontrib><creatorcontrib>WRIGHT, Jackson T</creatorcontrib><creatorcontrib>GERACI, Therese S</creatorcontrib><creatorcontrib>KINGRY, Connie</creatorcontrib><creatorcontrib>FORD, Charles E</creatorcontrib><creatorcontrib>PILLER, Linda B</creatorcontrib><creatorcontrib>BETTENCOURT, Judy</creatorcontrib><creatorcontrib>KIMMEL, Barbara</creatorcontrib><creatorcontrib>LUSK, Christine</creatorcontrib><title>Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues</title><title>Controlled clinical trials</title><subject>Biological and medical sciences</subject><subject>Clinical trial. Drug monitoring</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0197-2456</issn><issn>1879-050X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNjU1Ow0AMhUcIJMLPHSyxgUWkSWiall1UgbqIBIss2FVW6lBDMhON3UI5DidlinoANvbTe5-fT0ySzcp5agv7emoSm83LNJ8U03NzIfJurS2y6SQxP88jBVT2DntAGalVAd-BUhjYxcC9gW4I1v4Lv72wAwzDHxDNyilv9rFAyQnvCNCtoeaR4_SfFA7HTSDUgZyCengJtDvIJWFQqFSx_YgEx9-3VV0vq-YOHmDReyG_VWCRLcmVOeuwF7o-7ktz8_TYLJbpiNJi3wV0LctqDDxg2K9mpc3y_P5_1C9Rg187</recordid><startdate>2001</startdate><enddate>2001</enddate><creator>PRESSEL, Sara L</creator><creator>DAVIS, Barry R</creator><creator>PARKS, Heather</creator><creator>SIMPSON, Lara M</creator><creator>NWACHUKU, Chuke</creator><creator>FURBERG, Curt D</creator><creator>WRIGHT, Jackson T</creator><creator>GERACI, Therese S</creator><creator>KINGRY, Connie</creator><creator>FORD, Charles E</creator><creator>PILLER, Linda B</creator><creator>BETTENCOURT, Judy</creator><creator>KIMMEL, Barbara</creator><creator>LUSK, Christine</creator><general>Elsevier Science</general><scope>IQODW</scope></search><sort><creationdate>2001</creationdate><title>Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues</title><author>PRESSEL, Sara L ; DAVIS, Barry R ; PARKS, Heather ; SIMPSON, Lara M ; NWACHUKU, Chuke ; FURBERG, Curt D ; WRIGHT, Jackson T ; GERACI, Therese S ; KINGRY, Connie ; FORD, Charles E ; PILLER, Linda B ; BETTENCOURT, Judy ; KIMMEL, Barbara ; LUSK, Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_8701223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Biological and medical sciences</topic><topic>Clinical trial. Drug monitoring</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PRESSEL, Sara L</creatorcontrib><creatorcontrib>DAVIS, Barry R</creatorcontrib><creatorcontrib>PARKS, Heather</creatorcontrib><creatorcontrib>SIMPSON, Lara M</creatorcontrib><creatorcontrib>NWACHUKU, Chuke</creatorcontrib><creatorcontrib>FURBERG, Curt D</creatorcontrib><creatorcontrib>WRIGHT, Jackson T</creatorcontrib><creatorcontrib>GERACI, Therese S</creatorcontrib><creatorcontrib>KINGRY, Connie</creatorcontrib><creatorcontrib>FORD, Charles E</creatorcontrib><creatorcontrib>PILLER, Linda B</creatorcontrib><creatorcontrib>BETTENCOURT, Judy</creatorcontrib><creatorcontrib>KIMMEL, Barbara</creatorcontrib><creatorcontrib>LUSK, Christine</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Controlled clinical trials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PRESSEL, Sara L</au><au>DAVIS, Barry R</au><au>PARKS, Heather</au><au>SIMPSON, Lara M</au><au>NWACHUKU, Chuke</au><au>FURBERG, Curt D</au><au>WRIGHT, Jackson T</au><au>GERACI, Therese S</au><au>KINGRY, Connie</au><au>FORD, Charles E</au><au>PILLER, Linda B</au><au>BETTENCOURT, Judy</au><au>KIMMEL, Barbara</au><au>LUSK, Christine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues</atitle><jtitle>Controlled clinical trials</jtitle><date>2001</date><risdate>2001</risdate><volume>22</volume><issue>1</issue><spage>29</spage><epage>41</epage><pages>29-41</pages><issn>0197-2456</issn><eissn>1879-050X</eissn><cop>New York, NY</cop><pub>Elsevier Science</pub></addata></record>
fulltext fulltext
identifier ISSN: 0197-2456
ispartof Controlled clinical trials, 2001, Vol.22 (1), p.29-41
issn 0197-2456
1879-050X
language eng
recordid cdi_pascalfrancis_primary_870122
source ScienceDirect Freedom Collection
subjects Biological and medical sciences
Clinical trial. Drug monitoring
General pharmacology
Medical sciences
Pharmacology. Drug treatments
title Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) : Closeout issues
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A04%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Operational%20aspects%20of%20terminating%20the%20doxazosin%20arm%20of%20the%20Antihypertensive%20and%20Lipid%20Lowering%20Treatment%20to%20Prevent%20Heart%20Attack%20Trial%20(ALLHAT)%20:%20Closeout%20issues&rft.jtitle=Controlled%20clinical%20trials&rft.au=PRESSEL,%20Sara%20L&rft.date=2001&rft.volume=22&rft.issue=1&rft.spage=29&rft.epage=41&rft.pages=29-41&rft.issn=0197-2456&rft.eissn=1879-050X&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E870122%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_8701223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true